The management of superficial bladder cancer: an interactive seminar.
OBJECTIVE
To determine the current management of superficial bladder cancer in the United Kingdom.


METHODS
An interactive seminar with a series of questions about management and hypothetical clinical scenarios was conducted at the 1995 conference of the British Association of Urological Surgeons. The responses of the audience were recorded electronically and analysed.


RESULTS
The results showed that there is a wide variation in practice and some confusion over the place of intravesical treatment using cytotoxic drugs and bacille Calmette-Guérin.


CONCLUSIONS
The management of superficial bladder cancer could be improved by a more widespread use of intravesical therapy, along with the introduction of local protocols and national guidelines.
McFarlane
J P
JP
Institute of Urology and Nephrology, St Peter's Hospital, London, UK.
Ellis
B W
BW
Harland
S J
SJ
D000283:Administration, Intravesical; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001500:BCG Vaccine / Q000627:therapeutic use*; D001706:Biopsy; D017024:Chemotherapy, Adjuvant; D006417:Hematuria / Q000628:therapy; D006801:Humans; D001749:Urinary Bladder Neoplasms / Q000628:therapy*
D000970:Antineoplastic Agents; D001500:BCG Vaccine